menu
    • menu

    Company profile for Vaxart

    NEW Drugs in Dev: 20
    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    IKF/Pharmasynthese have been with fine chemicals market and APIs performance for more than 40 years.

    Virtual Booth

    Contact Supplier

    Cosma S.p.A., part of CFM Group with AMSA & Clarochem, provides global pharma & veterinary health with 300+ tons of FDA-approved APIs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Our mission is the promotion of global health through the development of effective vaccines that can be administered by tablet rather than by injection, providing for the simple and efficient distribution and administration of safe vaccines in any setting.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VaxartUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    385 Oyster Point Blvd., Suite 9A South San Francisco, CA 94080
    Telephone
    Telephone
    +1 650 550 3500
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://vaxart.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    SCOPE Summit

    SCOPE Summit

    Not Confirmed

    envelop Contact Supplier

    SCOPE Summit

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Vaxart Releases Positive Data On Oral Norovirus Vaccine
    Vaxart Releases Positive Data On Oral Norovirus Vaccine

    15 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/15/3219496/25416/en/Vaxart-Publishes-Positive-Data-for-its-Oral-Bivalent-Norovirus-Candidate-in-Lactating-Women-and-Their-Infants.html

    GLOBENEWSWIRE
    15 Jan 2026
    Share Share
    Vaxart Joins Global Bioinnovation Forum On Jan 13, 2026
    Vaxart Joins Global Bioinnovation Forum On Jan 13, 2026

    08 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/08/3215773/25416/en/Vaxart-to-Participate-in-the-Global-BioInnovation-Forum-on-January-13-2026.html

    GLOBENEWSWIRE
    08 Jan 2026
    Share Share
    Vaxart Updates Business And Reports Q3 2025 Financials
    Vaxart Updates Business And Reports Q3 2025 Financials

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187817/25416/en/Vaxart-Provides-Business-Update-and-Reports-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Vaxart To Host Upcoming Conference Calls
    Vaxart To Host Upcoming Conference Calls

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183604/25416/en/Vaxart-to-Host-Upcoming-Conference-Calls.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Dynavax Enters License Agreement for Vaxart's Oral COVID Vaccine
    Dynavax Enters License Agreement for Vaxart's Oral COVID Vaccine

    05 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/dynavax-enters-exclusive-license-agreement-for-vaxarts-novel-oral-covid-19-vaccine-program-302606056.html

    PR NEWSWIRE
    05 Nov 2025
    Share Share
    Vaxart To Showcase Next-Gen Norovirus Oral Vaccine At Idweek 2025
    Vaxart To Showcase Next-Gen Norovirus Oral Vaccine At Idweek 2025

    20 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/20/3169309/25416/en/Vaxart-to-Present-Research-on-Second-Generation-Norovirus-Oral-Pill-Vaccine-Candidate-at-IDWeek-2025.html

    GLOBENEWSWIRE
    20 Oct 2025
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    Inspections and registrations

    Upload your audits for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search